Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
443
-
Total 13F shares, excl. options
-
59.8M
-
Shares change
-
+1.64M
-
Total reported value, excl. options
-
$7.99B
-
Value change
-
+$241M
-
Put/Call ratio
-
2.14
-
Number of buys
-
231
-
Number of sells
-
-214
-
Price
-
$133.67
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2025
532 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2025.
REPLIGEN CORP - COMMON STOCK (RGEN) has 443 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (6.14M shares), VANGUARD GROUP INC (5.04M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.51M shares), UNITED CAPITAL FINANCIAL ADVISORS, LLC (2.76M shares), FMR LLC (2.69M shares), STATE STREET CORP (1.8M shares), CITADEL ADVISORS LLC (1.68M shares), Point72 Asset Management, L.P. (1.44M shares), Holocene Advisors, LP (1.38M shares), and Champlain Investment Partners, LLC (1.34M shares).
This table shows the top 443 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.